Company Info
| Industry | Chemicals: Specialty |
|---|---|
| Sector | Process Industries |
| Employees | 3,229 |
| CEO | Mr. Kevin S. Crutchfield |
| Address | 9900 West 109th Street Suite 100, Overland Park, KS 66210 |
|---|---|
| Phone | 1.913.344.9200 |
| Website | www.compassminerals.com |
Compass Minerals International, Inc. engages in the production of salt, plant nutrients, and magnesium chloride for distribution in North America. It operates through the following segments: Salt, Plant Nutrition North America, and Plant Nutrition South America. The Salt segment offers products for use in road deicing and dust control, food processing, water softeners, and agricultural and industrial applications. The Plant Nutrition North America segment produces and markets sulfate of potash crop nutrients, industrial-grade SOP and micronutrients. The Plant Nutrition South America segment manufactures specialty plant nutrition solution-based products that are used in direct soil and foliar applications. The company was founded in 1993 and is headquartered in Overland Park, KS.
Competitors
| Company Name | 3 Month %Change |
1 Year %Change |
|---|---|---|
| Compass Minerals International, Inc. | -20.80% | -20.54% |
| Sealed Air Corp. | 4.09% | 39.65% |
| Olin Corp. | 22.62% | 153.89% |
| Scotts Miracle-Gro Co. | 2.50% | -4.71% |
| Owens Corning | -9.42% | 17.84% |
Statement Summary
as of 4:10 ET PM 11/24/2021| Total Assets (MRQ) | 1.6 B |
|---|---|
| Total Liabilities (MRQ) | 1.3 B |
| Shareholders’ Equity (MRQ) | 293.1 M |
| Total Revenue (Annual) | 211.7 M |
| Net Income (Annual) | -56.0 M |
Earnings And Estimates
as of 4:10 ET PM 11/24/2021
| Current Qtr EPS Estimate | 0.58 |
|---|---|
| Current FY EPS Estimate | 0.64 |
| Long Term EPS Growth Estimate | 38.71 |
| Next Expected Earnings Date | 5/3/2022 |
CMP vs S&P 500
as of 11/24/2021| Relative To S&P 500 |
CMP | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 4:10 ET PM 11/24/2021| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/2021 | 0.26 | -0.14 | -154.51% |
| 06/2021 | -0.05 | -0.49 | +827.03% |
| 03/2021 | 0.64 | 0.95 | +49.31% |
| 12/2020 | 1.34 | 0.62 | -53.79% |
| 09/2020 | 0.44 | -0.07 | -115.83% |
| 06/2020 | -0.18 | 0.04 | -121.90% |
| 03/2020 | 0.57 | 0.80 | +39.38% |
| 12/2019 | 1.82 | 1.66 | -9.07% |
Financial Strength
as of 4:10 ET PM 11/24/2021| Pre-Tax Margin | -3.83 |
|---|---|
| Net Margin | -145.45 |
| Operating Margin | 0.99 |
| Return On Equity | 14.06 |
| Return On Assets | 2.29 |
| Inventory Turnover (TTM) | 2.83 |
| Sales Growth (MRQ) | -1.77 |
Ratios
as of 4:10 PM ET 11/24/2021| Price/Earnings (TTM) | n/a |
|---|---|
| Price/Book (MRQ) | 9.37 |
| Price/Cash Flow (TTM) | 11.73 |
| Book Value (MRQ) | 0.00 |
| Quick Ratio (MRQ) | 1.07 |
| Current Ratio (MRQ) | 2.72 |
| Total Debt/Equity (MRQ) | 3.19 |
Short Interest
as of 1:10 PM ET 11/26/2021| % Short - 3.41% | |
| % Remaining Float - 96.59% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | 11/15/2021 | 10/29/2021 |
| Short Interest Shares | 1,151,193 | 1,251,980 |
| Short Interest Ratio | 6.3 | 5.2 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 4:10 ET PM 11/24/2021| Current Qtr (12/2021) |
Next Qtr (03/2022) |
|
|---|---|---|
| Consensus Estimate | $0.58 | $0.90 |
| # of Estimates | 6 | 6 |
| High Estimate | $0.78 | $1.16 |
| Low Estimate | $0.26 | $0.66 |
| Year Ago EPS | $0.95 | $-6.60 |
| Year Over Year Growth Estimate | -39.02% | -113.59% |
| Current Yr (09/2021) |
Next Yr (09/2022) |
|
|---|---|---|
| Consensus Estimate | $0.64 | $1.48 |
| # of Estimates | 4 | 7 |
| High Estimate | $0.78 | $2.45 |
| Low Estimate | $0.59 | $1.02 |
| Year Ago EPS | $1.39 | $0.64 |
| Year Over Year Growth Estimate | -53.75% | 129.55% |
| Current Qtr (12/2021) |
Next Qtr (03/2022) |
Current Year (09/2021) |
Next Year (09/2022) |
|
|---|---|---|---|---|
| Consensus Estimate | $0.58 | $0.90 | $0.64 | $1.48 |
| # of Estimates | 6 | 6 | 4 | 7 |
| High Estimate | $0.78 | $1.16 | $0.78 | $2.45 |
| Low Estimate | $0.26 | $0.66 | $0.59 | $1.02 |
| Year Ago EPS | $0.95 | $-6.60 | $1.39 | $0.64 |
| Year Over Year Growth Estimate | -39.02% | -113.59% | -53.75% | 129.55% |
Insider Information Summary
as of 10/31/2021| % Insiders - 0.94% | |
| % Remaining Total Shares - 99.06% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | 2.12 K | -11.80 K |
| Shares Bought | 15.18 K | 15.71 K |
| Shares Sold | 13.06 K | 27.51 K |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Learn to Trade Like a Pro
Master The Market with the Help of Our Financial Experts
LATEST NEWS
Top Five Stock Gainers for Wednesday: Compass Minerals, Covanta
Jul 14, 2021 4:42 PM EDT
Latest News
Trade-Ideas: Compass Minerals International (CMP) Is Today's "Barbarian At The Gate" Stock
Jul 26, 2016 11:53 AM EDT
Analysts' Actions -- Best Buy, Salesforce, Cisco, P&G and More
Jun 15, 2016 8:12 AM EDT
Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: PEI, CMP, EXPD
May 26, 2016 10:00 AM EDT
3 Buy-Rated Dividend Stocks: CMP, CCI, T
Apr 7, 2016 11:30 AM EDT
Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: BCRH, BOBE, CMP
Feb 24, 2016 10:00 AM EST
3 Buy-Rated Dividend Stocks Leading The Pack: VZ, PPL, CMP
Feb 18, 2016 10:30 AM EST
3 Stocks With Upcoming Ex-Dividend Dates: SSI, CMP, CDK
Nov 25, 2015 10:00 AM EST
Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: WMS, CMP, EXPD
May 27, 2015 10:00 AM EDT
Analysts' Actions -- Twitter, Procter & Gamble, Marvell Technology and More
Apr 29, 2015 8:31 AM EDT
3 Stocks Going Ex-Dividend Tomorrow: STB, MDP, CMP
Feb 24, 2015 10:00 AM EST
Generac, Douglas Dynamics Among Stocks To Watch As Storm Slams Northeast
Jan 26, 2015 10:44 AM EST
Compass Minerals International (CMP) Upgraded From Hold to Buy
Dec 2, 2014 9:08 AM EST
3 Stocks With Upcoming Ex-Dividend Dates: SLGN, CMP, EXPD
Nov 25, 2014 10:22 AM EST
Tomorrow's Ex-Dividends To Watch: CFD, MLHR, CMP
Aug 26, 2014 10:05 AM EDT
Why compass minerals international (cmp) stock is retreating today
Jul 28, 2014 11:47 AM EDT
Tomorrow's Ex-Dividends To Watch: MTR, BIP, CMP
May 27, 2014 10:06 AM EDT
Will This Upgrade help Compass Minerals (CMP) Stock Today?
Apr 30, 2014 9:30 AM EDT
Analysts' Actions: CERN COH COLM HRS TCBI
Apr 30, 2014 8:21 AM EDT
Compass Minerals International (CMP) Marked As A Barbarian At The Gate
Apr 29, 2014 10:19 AM EDT
Dividend Watch: 3 Stocks Going Ex-Dividend Tomorrow: FAX, CMP, EXXI
Feb 25, 2014 10:00 AM EST
'Fast Money' Recap: A Stunning Move
Feb 25, 2014 5:00 AM EST
Compass Minerals International Inc. Stock Upgraded (CMP)
Feb 12, 2014 10:11 AM EST
Why Compass Minerals (CMP) Was Upgraded
Feb 6, 2014 9:16 AM EST
3 Stocks Spiking on Unusual Volume
Jan 7, 2014 7:00 AM EST
Recent Articles from TheStreet
Hyatt Shares Rise on J.P. Morgan Upgrade to Overweight
'We are using the 10% pullback from share price levels earlier in the month to get more aggressive on Hyatt,' the bank writes.
Walmart CFO Brett Biggs Leaving After 22 Years
Walmart says Biggs stay on as CFO until a successor is named and will remain as an associate until he leaves in January 2023.
Bristol Myers Stock Falls Despite Positive News on Psoriasis Drug
Bristol Myers shares fall after the FDA accepts its psoriasis-treating deucravacitinib drug application, and European regulators also validate its application.
Best Buy, Big-Box Store Inventory Strong, Roku Demand High: Wedbush
Wedbush finds no shortage of in-store inventory for consumer electronics. And it says Roku products are in strong demand.
Twitter Stock Leaps Amid Report CEO Jack Dorsey Will Step Down
Twitter co-founder Jack Dorsey is set to step-down as CEO of the microblogging website, CNBC reported Monday.
Wells Fargo Bullish on Quality Stocks, Despite Omicron
'We do not recommend de-risking into weakness,' Chris Harvey, head of equity strategy for Wells, writes in a commentary.
Amazon Invests in Bypassing Retail Supply Chain Issues
Amazon has built more than 450 new facilities nationwide in recent months in order to beat supply chain issues.
Cryptocurrency Price Check: Bitcoin Bounces Back After Omicron Scare
Bitcoin 'is leading the market back from the depths of despair,' a cryptocurrency analyst says.
Premarket Movers Monday: Moderna, Zoom Video
Stock futures rose Monday amid travel curbs tied to the omicron Covid variant.
Pfizer Stock Jumps On Plan To Boost Covid Pill Production In Fight Against Omicron Variant
Pfizer CEO Albert Bourla confirmed the drugmaker's plans to boost production of its Paxlovid antivrical treatment in the first against the spread of the new Omicron variant.